Portfolio companies

 
 
Heart-on-a-chip   Engineered human cardiac tissues that exhibit unprecedented functional maturity.

Heart-on-a-chip

Engineered human cardiac tissues that exhibit unprecedented functional maturity.

 
CRISPR-based diagnostics   CRISPR-based platform building an extensive variety of tests for bio sensing in healthcare, agriculture, manufacturing, and forensics.

CRISPR-based diagnostics

CRISPR-based platform building an extensive variety of tests for bio sensing in healthcare, agriculture, manufacturing, and forensics.

 
Personalized 3D skeletal grafts   Digitally designed, made of stem cells, cultivated through bioreactors personalized bone grafts.

Personalized 3D skeletal grafts

Digitally designed, made of stem cells, cultivated through bioreactors personalized bone grafts.

 
 
Bioactive tissue repair   Quthero enables full epithelial restoration via collective migration of cells.

Bioactive tissue repair

Quthero enables full epithelial restoration via collective migration of cells.

 
RNA precision platform   Develops tests to predict response to blockbuster drugs & new targeted therapies.

RNA precision platform

Develops tests to predict response to blockbuster drugs & new targeted therapies.

 
siRNA delivery platform   Their siRNA delivery platform allows for selective choice of therapeutic targets.

siRNA delivery platform

Their siRNA delivery platform allows for selective choice of therapeutic targets.

 
 
Anti-infectives platform   Rapidly & effectively developing novel peptide anti-infectives therapeutics.

Anti-infectives platform

Rapidly & effectively developing novel peptide anti-infectives therapeutics.

 
“One pill a day” to treat T1D   Exploiting the natural plasticity of cells in the gut to treat insulin-dependent diabetes.

“One pill a day” to treat T1D

Exploiting the natural plasticity of cells in the gut to treat insulin-dependent diabetes.

 
High throughput drug discovery   Disruptive high-throughput drug discovery platform for monoclonal antibodies (mAb)

High throughput drug discovery

Disruptive high-throughput drug discovery platform for monoclonal antibodies (mAb)